Skip to main content
Home

Main navigation

  • Why NYC & LifeSci
    • $500M Investment in Life Sciences
    • State of the Industry
    • Landmarks Map
  • Key Resources
Toggle navigation

Slideout menu

  • About
    • Advisory Council
    • Partners
    • Staff
  • Expansion Funds Application
  • Internship Program
    • Overview & Program Details
    • Student Application
    • Host Application
    • For Students
    • For Hosts
    • News & Achievements
    • FAQ
  • Key Resources
  • Why LifeSci & NYC
    • $500M Investment in Life Sciences
    • State of the Industry
    • Landmarks Map
  • Events
  • News
  • Contact

Stay in touch

Sign up to receive opportunity updates and exclusive event invitations.

 
 

News

quentis nyc

NYCEDC Grants $1M To Quentis Therapeutics For Expansion of LifeSci Space in West Harlem

First grant to be distributed from $10M LifeSci NYC Expansion Fund
Announcements

City offers $10M for biotech startups to expand

The City Economic Development Corp. is deploying a $10 million fund to help life sciences companies expand in the city.
Press

Life Sciences Expansion Funds Application

The New York City Economic Development Corporation, on behalf of the City of New York, is pleased to provide a funding opportunity to life sciences companies interested in expanding their operations in one of the City’s five boroughs.
Alexandria phase 3

De Blasio Administration and Alexandria Real Estate Equities, Inc. Finalize Deal for Expansion of Life Sciences R&D Campus in Kips Bay

The proposed 550,000 square-foot facility will serve as a valuable resource to the City’s emerging life sciences industry.
Announcements

Biz Group Pitches Long Island City as Next Life Sciences Hub

Long Island City would be an ideal place for a life-sciences hub, according to a new study by a local business group.
From the Community

Alexandria Real Estate Equities buys LIC building for $75M

Alexandria Real Estate Equities is bringing one of its life-science centers to Long Island City.
From the Community

In New York, Gotham Starts Up With $54M for RNA-Modifying Drugs

A new company has emerged from New York City’s growing startup biotech scene.
From the Community

Crash Course in Strategy

Armand Avetisian spent the summer of 2018 as a business development intern at EpiVax Oncology in New York City, where he worked side-by-side with the company’s CEO and Co-Founder, Gad Berdugo.
Press
rgenix nyc

Rgenix bags $40M to advance cancer drugs, including GSK castoff

New York biotech Rgenix has raised $40 million in series C financing to carry out early and mid-stage trials for a pair of cancer drugs.
From the Community
Hudson Research Center NYC

Silverstein, Taconic Unveil Pre-built Wet Lab at Hudson Research Center

Silverstein Properties and Taconic Investment Partners, joint venture owners of 619 West 54th Street, have unveiled the first pre-built wet lab to hit the market at their Hudson Research Center.
From the Community

Taconic and Silverstein Bring New Lab Space to the Far West Side

Taconic Investment Partners and Silverstein Properties are transforming a former warehouse at 619 West 54th Street into a mix of science labs and creative office space known as the Hudson Research Center.
From the Community

FierceBiotech's 2018 Fierce 15

NYC-based companies Kallyope and Quentis Therpeutics named "Fierce 15" winners in 2018.
From the Community

Can NYC shed its test-tube status?

NYC is pushing further into the burgeoning life science and biotech fields.
From the Community
JLabs NYC

A Look Inside Johnson and Johnson's New Startup Incubator in NYC

Johnson & Johnson Innovation's Manhattan outpost of its startup incubator, JLabs, is the new kid on the NYC-health-tech block.
From the Community
lucerna aminoor rashid

A Day In the Life of a LifeSci NYC Intern: Aminoor Rashid

Aminoor Rashid spent the summer at Lucerna, Inc., an R&D company working to create tools to visualize and study RNA.
From Our Partners

Startup Launches with $31M to take on 'Chemo Brain'

VC incubator Accelerator Life Science Partners launched its latest biotech startup Monday with a $31 million Series A investment from the likes of Pfizer, Eli Lilly, and AbbVie. The company, Magnolia Neurosciences, aims to develop treatments for a range of neurodegenerative conditions.
From the Community

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Current page 3
  • Page 4
  • Page 5
  • Next page Next ›
  • Last page Last »

Submit your news

Get in touch
Home
NYCEDC New York City Economic Development Corporation
One Liberty Plaza
New York, NY 10006
https://edc.nyc
NYC Office of the Mayor
Mayor Bill de Blasio
City Hall, New York, NY 10007
http://nyc.gov

Stay in touch

Sign up to receive opportunity updates and exclusive event invitations.
© 2021. NYCEDC. All Rights Reserved.

Footer menu

  • Contact
  • Privacy Policy
  • Terms of Use